Venture Capital

Micron Biomedical: $43 Million In Total Grant Support Raised To Improve Coverage Of Measles And Rubella Vaccine

By Amit Chowdhry ● Jan 9, 2025

Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines based on dissolvable microarrays, announced the company secured a $7.5 million grant from the Bill & Melinda Gates Foundation that brings total grant funding from the organization to $43 million.

Innovaccer: Healthcare AI Company Raises $275 Million (Series F)

By Amit Chowdhry ● Jan 9, 2025

Innovaccer - a leading healthcare AI company - announced a $275 million Series F funding round. This round was a combination of primary and secondary and included participation from B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.

Hippocratic AI: Healthcare LLM Company Raises $114 Million (Series B) At $1.64 Billion Valuation

By Amit Chowdhry ● Jan 9, 2025

Hippocratic AI (see Pulse 2.0 profile here), the company that pioneered the first healthcare LLM for patient-facing non-diagnostic clinical tasks, announced that the company completed its series B financing round only nine months after its series A. The series B raised $141 million, valuing the company at $1.64 billion. The funding round was led by Kleiner Perkins. They were joined by existing investors: A16z, General Catalyst, Premji, NVIDIA, SV Angel, Universal Health Services (UHS), and WellSpan Health, which all participated at or above pro-rata.

Evergreen Nephrology: Kidney Care Company Raises $130 Million

By Amit Chowdhry ● Jan 9, 2025

Evergreen Nephrology, a leader in value-based kidney care, announced it has raised $130 million in capital to expand its care model to more patients living with kidney disease. This funding was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures.

DDN: AI And Data Intelligence Solutions Company Raises $300 Million At $5 Billion Valuation

By Amit Chowdhry ● Jan 9, 2025

DDN, a leader in AI and data intelligence solutions, announced it has received a $300 million investment from funds managed by Blackstone Tactical Opportunities at a $5 billion valuation. This investment will help fund DDN’s continued rapid growth as it serves its customers’ fast-expanding AI and high-performance computing (HPC) software and infrastructure needs.

OnPay: Benefits Solution Company Raises Over $100 Million

By Amit Chowdhry ● Jan 9, 2025

OnPay, a leading provider of payroll, HR, and benefits solutions, announced that it has secured over $100 million in funding. This funding consists of a $63 million Series B funding round led by Carrick Capital Partners, with participation from AB Private Credit Investors, the middle market private capital platform of AllianceBernstein, and existing investors, and a debt facility provided by MC Credit Partners.

Citrin Cooperman To Raise Investment From Blackstone

By Amit Chowdhry ● Jan 9, 2025

Citrin Cooperman Advisors - a premier tax, advisory, and accounting provider for private middle-market businesses and high-net-worth individuals - announced a definitive agreement for a significant investment from private equity funds managed by Blackstone. Blackstone is acquiring its stake in the firm from New Mountain Capital as part of the transaction.

Stellar: AI-Based Business Solutions Company Raises $2.7 Million (Seed)

By Amit Chowdhry ● Jan 9, 2025

Stellar, a leader in AI-based business solutions, announced that it has raised $2.7 million in a seed funding round. This funding round was led by Ground Game, with additional participation from Elevate Ventures, a leading seed and early-stage investor in the Great Lakes Region. Ground Game and Elevate Ventures joined as new investors in the oversubscribed seed round.

Alta Resource: $5.1 Million (Seed) Funding Raised To Transform Mineral Separation

By Amit Chowdhry ● Jan 9, 2025

Alta Resource Technologies, a pioneer in utilizing advanced biochemistry to transform mineral separation, announced it has raised $5.1 million in an oversubscribed seed round co-led by DCVC and Voyager Ventures, with participation from Orion Industrial Ventures, Overture, and WovenEarth Ventures.

Infinite Reality: Immersive Technology Company Raises $3 Billion At $12.25 Billion Valuation

By Amit Chowdhry ● Jan 9, 2025

Sixth Street To Manage $13 Billion Of Northwestern Mutual’s Assets

By Amit Chowdhry ● Jan 9, 2025

Northwestern Mutual (a leading financial services provider of insurance and wealth products) and Sixth Street (a leading global investment firm) announced a new strategic partnership to support Northwestern Mutual’s long-term and diversified investment strategy for its institutional investment portfolios, which total over $320 billion. Under this partnership, Sixth Street will manage $13 billion of assets for Northwestern Mutual with the potential to scale. As part of the deal, Northwestern Mutual will acquire a minority equity interest in Sixth Street.

Nassau Financial Group Receiving $200 Million Minority Equity Investment From Golub

By Amit Chowdhry ● Jan 9, 2025

Nassau Financial Group (a leading provider of fixed annuities and asset management) and Golub Capital (a market-leading direct lender and experienced credit asset manager) have closed on their previously announced strategic partnership after satisfaction of closing conditions.

Pison: AI-Based Neural Sensor Company Raises Funding From Samsung Ventures

By Amit Chowdhry ● Jan 9, 2025

Pison, an AI-based neural sensors for cognitive health, wellness, and gesture control, announced an equity investment from Samsung Ventures. This funding highlights the dedication of Samsung Ventures to advancing future healthcare technology and acknowledges Pison’s potential in neurocognitive assessment and tracking capabilities.

Trinity Ventures Closes $435 Million Continuation Fund With Partners Group

By Amit Chowdhry ● Jan 9, 2025

Trinity Ventures, an early-stage technology venture capital firm, announced the closing of Trinity Ventures 2024, LP, a multi-asset continuation fund with about $435 million in total commitments. The new fund was formed to recapitalize a group of portfolio companies from Trinity Ventures XI, LP, a 2012 vintage fund.

Francis Medical: $80 Million (Series C) Raised To Develop Water Vapor Ablation Therapy For Treating Cancer

By Amit Chowdhry ● Jan 9, 2025

Francis Medical - a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer- announced the completion of the company's oversubscribed $80 million Series C equity funding, the most significant fundraising round to date for the company. Arboretum Ventures and Solas BioVentures co-led the Series C round. And new investors Orlando Health Ventures and two additional strategic partners joined this round, along with previous investors Coloplast A/S and Tonkawa.

Pepticom: Peptide-Based Therapeutics Company Raises $6.6 Million (Series A1)

By Amit Chowdhry ● Jan 9, 2025

Pepticom, a pioneer in AI-based peptide-based therapeutics, announced the completion of its Series A1 funding round, securing $6.6 million. Japan Israel High Tech Ventures 2 LP led the round, with strong participation from existing investors.

Fort Partners Secures $107.6 Million Construction Loan From Madison Realty

By Amit Chowdhry ● Jan 9, 2025

Madison Realty Capital, a vertically integrated real estate private equity firm focused on real estate private credit, announced that it has provided a $107.6 million loan to an affiliate of Fort Partners for the completion of Seaway North at The Surf Club, which is an ultra-luxury residential condominium project located adjacent to the Four Seasons Hotel and Residences at The Surf Club in the Surfside neighborhood of Miami.

Northern Light: $23 Million Raised From LoneTree Capital

By Amit Chowdhry ● Jan 9, 2025

Northern Light Group, a leading enterprise knowledge management platform for competitive intelligence and market research, announced a $23 million growth investment by LoneTree. The funding will accelerate Northern Light's ability to scale, providing capital and resources to drive continued product innovation and enhance its ability to support enterprise customers worldwide.

Electric Power Engineers: Strategic Growth Investment Raised From Berkshire Partners

By Amit Chowdhry ● Jan 9, 2025

Electric Power Engineers (EPE), a leading energy and power systems engineering and consulting firm, announced it received a significant strategic growth investment from Boston-based private equity firm Berkshire Partners.

CourseKey Raises Strategic Growth Investment From PSG

By Amit Chowdhry ● Jan 9, 2025

PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled service companies to help navigate and capitalize on transformational growth, announced a strategic growth investment in CourseKey - a student success platform purpose-built for vocational education. CourseKey joins PSG's investments in Verity IQ and Campus Ivy, which creates a unified and end-to-end technology suite for career-focused and vocational education providers.

Deciphex: $32.3 Million (Series C) Raised For Addressing The Global Pathology Crisis

By Amit Chowdhry ● Jan 9, 2025

Deciphex, an AI-based digital pathology leader, announced it has closed its Series C funding at $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories, IRRUS Investments, HBAN Medtech Syndicate, and Nextsteps Capital, this funding will advance Deciphex's mission to democratize access to high-quality pathology through a technology-enabled global network of pathologists.

FIRE1: $120 Million Funding Raised For Transforming Heart Failure Care

By Amit Chowdhry ● Jan 9, 2025

FIRE1 - a leading connected medical device solutions company - announced the completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. The funding round was led by Polaris Partners and Elevage Medical Technologies and joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise Associates), Novo Holdings, and Seventure Partners.

Jones: Insurance Verification Company Raises $15 Million (Series B)

By Amit Chowdhry ● Jan 9, 2025

Jones, the vertical software company leading AI innovation in insurance verification, announced the closing of its $15 million Series B funding round led by NewSpring Growth. The funding round also saw continued participation from major existing investors, including Hetz Ventures, Camber Creek, Khosla Ventures, JLL Spark, DivcoWest Ventures, Rudin Ventures, and Ground Up Ventures.

XyloCor Therapeutics: $67.5 Million (Series B) Raised For Advancing Clinical Development Of Gene Therapy In Cardiovascular Disease

By Amit Chowdhry ● Jan 8, 2025

XyloCor Therapeutics - a clinical-stage biopharmaceutical company developing novel gene therapies for cardiovascular disease - announced the completion of a $67.5 million Series B financing. And the new investment will support a randomized, double-blind Phase 2b clinical trial (EXACT-2) of XC001 (encoberminogene rezmadenovec), in refractory angina, using a new non-surgical method of endocardial administration via a novel injection catheter.

Waterpoint Lane: Fund I Closed To Advance Food Innovation

By Amit Chowdhry ● Jan 8, 2025

Waterpoint Lane announced the closing of its inaugural fund, Waterpoint Lane Sustainability Fund I. Fund I attracted strong support from a distinguished global investor base, including premier family offices and high-net-worth individuals, all united by a commitment to advancing impact and innovation within the global food system.

Whatnot: Live Shopping Company Raises $265 Million (Series E) At $4.97 Billion Valuation

By Amit Chowdhry ● Jan 8, 2025

Whatnot, the largest marketplace focused on live shopping in the U.S., UK, and Europe, announced $265 million in Series E funding, co-led by Greycroft, DST Global, and Avra. Also joining are Greycroft and Avra, who are new investors. It also included Lightspeed Venture Partners and Durable Capital Partners, who participated in the round alongside returning investors Andreessen Horowitz (a16z), CapitalG, BOND, and Y Combinator. This investment brings Whatnot’s valuation to $4.97 billion. Since its founding, Whatnot has raised approximately $746 million.

Flavor Insights: Growth Financing Raised From BizCap

By Amit Chowdhry ● Jan 8, 2025

BizCap (a national commercial finance and advisory firm) announced it has delivered a customized financing solution for its client Flavor Insights. Flavor Insights is a flavor development business founded in 2016 and the company partners with top food and beverage brands to provide ingredients for existing brands and collaborates with R&D teams to develop and deliver new products.

MDaudit: Strategic Investment Raised From Bregal Sagemount And Primus Capital

By Amit Chowdhry ● Jan 8, 2025

MDaudit - a provider of billing, coding compliance, and revenue integrity software for health systems, hospitals, and provider groups - announced a strategic growth investment from Bregal Sagemount and Primus Capital. The terms of the deal were undisclosed.

Alesta Therapeutics: €65 Million (Series A) Raised To Develop Small Molecule Therapies For Rare Diseases

By Amit Chowdhry ● Jan 8, 2025

Alesta Therapeutics, a biotechnology company focused on developing transformative small molecule therapies for rare diseases, announced the closing of an oversubscribed €65 million Series A funding round. This funding round was co-led by Frazier Life Sciences and Droia Ventures, with participation from Novartis Venture Fund, RTW Investments, RV Invest, Thuja Capital, and SSI Strategy.

Aviceda Therapeutics: $207.5 Million (Series C) Raised To Develop Next-Generation Immunomodulators

By Amit Chowdhry ● Jan 8, 2025

Aviceda Therapeutics, a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS) nanotechnology platform to alleviate chronic, non-resolving inflammation, announced the closing of a $207.5 million Series C funding.